SlideShare ist ein Scribd-Unternehmen logo
1 von 42
ABORTION
ROD PRASAD
GROUP 3A
INTRODUCTION
 Abortion is defined as the spontaneous or induced termination of
pregnancy before fetal viability.
 Abortion is the process of partial or complete separation of the product of
conception from the uterine wall with or without partial or complete
expulsion from the uterine cavity before the age of viability.
 World Health Organization define abortion as pregnancy termination
before 20 weeks’ gestation or with a fetus born weighing < 500 g.
CLASSIFICATION
SPONTANEOUS ABORTION
 Spontaneous abortion is the most common complication of pregnancy and is defined as the
passing of a pregnancy prior to completion of the 20th gestational week.
 It implies delivery of all or any part of the products of conception, with or without a fetus
weighing less than 500g.
 80% of spontaneous abortions occur prior to 12 weeks' gestation.
 The incidence of abortion is influenced by the age of the mother and by a number of
pregnancy-related factors, including:
 a history of a previous full-term normal pregnancy,
 the number of previous spontaneous abortions,
 a previous stillbirth,
 and a previous infant born with malformations or known genetic defects.
ETIOLOGY
 An abnormal karyotype is present in approximately 50% of spontaneous abortions occurring during the
first trimester.
 The incidence decreases to 20–30% in second-trimester losses and to 5–10% in third trimester losses.
 Approximately half of miscarriages are anembryonic, that is, with no identifiable embryonic elements.
 Blighted ovum - represents a failed development of the embryo so that only a gestational sac, with or
without a yolk sac, is present.
 The other 50 percent are embryonic miscarriages, which commonly display a developmental
abnormality of the zygote, embryo, fetus, or at times, the placenta.
EMBRYONIC
ANEUPLOID VS
EUPLOID
Aneuploid Abortion - occurs at earlier gestational
ages. 75 percent of aneuploid abortions occurred
by 8 weeks.
Euploid Abortion - Chromosomally normal fetuses
abort later than those that are aneuploid.
Specifically, the rate of euploid abortions peaks at
approximately 13 weeks.
MATERNAL FACTORS
 INFECTIONS - Organisms such as Treponema pallidum, Chlamydia
trachomatis, Neisseria gonorrhoeae, Streptococcus agalactiae, herpes simplex
virus, cytomegalovirus, and Listeria monocytogenes have been implicated in
spontaneous abortion.
 OTHER MEDICAL CONDITIONS - Endocrine disorders such as
hyperthyroidism and poorly controlled diabetes mellitus; cardiovascular
disorders, such as hypertensive or renal disease; and connective tissue disease,
such as systemic lupus erythematosus.
 UTERINE DEFECTS - Congenital anomalies that distort or reduce the size of
the uterine cavity, such as unicornuate,bicornuate, or septate uterus, carry a
25–50% risk of miscarriage. Previous scarring of the uterine cavity following
dilatation and curettage (D&C), myomectomy, or unification procedures has
been implicated in spontaneous miscarriage.
MATERNAL FACTORS
 IMMUNOLOGICAL DISORDERS - Blood group incompatibility due to ABO, Rh, Kell, or other less common antigens
has been associated with spontaneous abortions.
 MALNUTRITION - severe dietary deficiency and morbid obesity are associated with increased miscarriage risks.
 SOCIAL & BEHAVIORAL FACTORS - increased miscarriage risk are most commonly related to chronic and especially
heavy use of legal substances. Eg, alcohol, cigarette smoking and caffeine.
 TOXIC FACTORS - Agents such as radiation, antineoplastic drugs, anesthetic gases, lead, ethylene oxide, and
formaldehyde may be embryotoxic.
 TRAUMA - Direct trauma, such as injury to the uterus from a gunshot wound, or indirect trauma, such as surgical
removal of an ovary containing the corpus luteum of pregnancy, may result in spontaneous abortion
PATHOLOGY OF PREGNANCY
 In spontaneous abortion, hemorrhage into the decidua basalis often
occurs.
 Necrosis and inflammation appear in the area of implantation. The
pregnancy becomes partially or entirely detached.
 Uterine contractions and dilatation of the cervix result in expulsion of most
or all of the products of conception.
THREATENED ABORTION
 DEFINITION
 Bleeding of intrauterine origin occurring
before the 20th completed week, with or
without uterine contractions, without
dilatation of the cervix, and without
expulsion of the products of conception.
 CLINICAL FEATURE
 Bleeding (minimal, painless)
 Clearly rhythmic cramps
 Persistent low backache with pelvic
pressure
 Dull and midline suprapubic discomfort.
 EXAMINATION
 Size of uterus is correspond to period of
amenorrhea (POA)
 Closed cervical os
 U/S : well-formed, rounded gestational
sac with fetus within it
 MANAGEMENT
 Bed rest
 Folic acid supplements
 Avoid coitus
INEVITABLE ABORTION
 DEFINITION
 Bleeding of intrauterine origin before the
20th completed week, with dilatation of the
cervix without expulsion of the products of
conception.
 It can progress to complete/ incomplete
abortion depending on whether or not all
fetal & placental tissues have been expelled
from uterus.
 CLINICAL FEATURE
 Vaginal bleeding (painful)
 Associated with cramping pain at lower
abdomen
 Abortion isinevitable when cervical
effacement, cervical dilatation, and/or
rupture of the membranes
 EXAMINATION
 Size of uterus is correspond to/less than
POA
 Dilated cervical os
 MANAGEMENT
 Hospitalization
 Analgesics for control of pain
INCOMPLETE ABORTION
 DEFINITION
 Expulsion of some, but not all, of the
products of conception
 CLINICAL FEATURE
 Vaginal bleeding (heavy, passed out
POC as fleshy masses)
 Associated with colicky pain at lower
abdomen
 +/- signs of shock
 EXAMINATION
 Size of uterus is smaller than POA
 Open cervical os
 U/S : reveal retained POC in uterine
cavity
 MANAGEMENT
 Resuscitate if bleeding is severe, do
blood group and cross match
 Give analgesia for pain
 Evacuation retained product of
conception
COMPLETE ABORTION
 DEFINITION
 Expulsion of all of the products of
conception before the 20th completed
week of gestation
 CLINICAL FEATURE
 History of pain and passage of
product of conception
 Followed by absent of pain, minimal
bleeding
 EXAMINATION
 Size of uterus is smaller than POA
 Closed cervical os
 U/S : empty uterine cavity
 MANAGEMENT
 Do U/S to look for empty of uterine
cavity
MISSED ABORTION
 DEFINITION
 The embryo or fetus dies, but the
products of conception are retained in
utero.
 CLINICAL FEATURE
 Decreased in pregnancy symptoms
 Vaginal bleeding (absent, minimal)
 EXAMINATION
 Size of uterus is smaller than POA •
 Closed cervical os •
 U/S : crumpled gestational sac and/or
revealed fetal pole but no signs of
activity (no heart activity)
 MANAGEMENT
 Wait for spontaneous expulsion
 Evacuation of retained product of
conception
SEPTIC ABORTION
 DEFINITION
 Infection of the uterus and sometimes
surrounding structures occur.
 CLINICAL FEATURE
 Fever
 Malodorous vaginal discharge
 Pelvic and abdominal pain
 EXAMINATION
 CBC, urinalysis, endometrial cultures,
blood cultures, chest x-ray, and
abdominal x-ray to rule out uterine
perforation.
 U/S: rule out retained products of
conception
 MANAGEMENT
 Hospitalization and intravenous
antibiotic therapy
 D&C and hysterectomy if the infection
does not respond to treatment.
TYPES OF
SPONTANEOUS
ABORTION
RECURRENT ABORTION
 Recurrent abortion in its broadest definition is defined as 2 to 3 or more
consecutive pregnancy losses before 20 weeks of gestation, each with a fetus
weighing less than 500g.
 Most of these are embryonic or early losses, and the remainder either are
anembryonic or occur after 14 weeks.
 Prognosis for a successful subsequent pregnancy is correlated with the number
of previous abortions.
 The risk of having a spontaneous abortion for the first time is about 15%, and
this risk is at least doubled in women experiencing recurrent abortion.
ETIOLOGY
 There are many putative causes of recurrent abortion, however,only three
are widely accepted:
1. Parental Chromosomal Abnormalities
 Account for only 2 to 4 percent of recurrent losses
 Karyotypic evaluation of both parents is considered by many to be a critical
part of evaluation.
 Balanced reciprocal translocations – 50%
 Robertsonian translocations – 25%
 X chromosome mosaicism - 47,XXY or Klinefelter syndrome - 12 %
 These chromosomal abnormalities are repetitive for consecutive losses
ETIOLOGY
2. Anatomical Factors
 Several genital tract abnormalities have been implicated in recurrent miscarriage and other adverse
pregnancy outcomes, but not infertility.
 Asherman syndrome usually result from destruction of large areas of endometrium following
uterine curettage or ablative procedures.
 Cervical incompetence, submucous leiomyomas, abnormalities due to Diethylstilbestrol (DES)
exposure in utero.
 Septate uteri account for the vast majority of patients with uterine malformations and recurrent
pregnancy loss.
 Submucous leiomyomas are responsible for a much smaller percentage of repeated losses
UTERINE MALFORMATIONS
ETIOLOGY
3. Antiphospholipid Syndrome
 Antiphospholipid antibodies, a family of autoantibodies that bind to
phospholipid-binding plasma proteins.
 Women with recurrent spontaneous pregnancy loss have a higher frequency of
these antibodies compared with normal pregnancies.
 Antiphospholipid antibodies may damage platelets and vascular endothelium,
resulting in thrombosis.
 Other suspected but not proven causes are alloimmunity,
endocrinopathies, environmental toxins, and various infections.
DIAGNOSIS AND
TREATMENT
INDUCED ABORTION
 The term induced abortion is defined as the medical or surgical termination of
pregnancy before the time of fetal viability.
 Definitions to describe its frequency include:
(1) abortion ratio - the number of abortions per 1000 live births, and
(2) abortion rate - the number of abortions per 1000 women aged 15 to 44 years.
 An estimated 1 of every 4 pregnancies in the world is terminated by induced
abortion, making it perhaps the most common method of reproduction limitation.
 Midtrimester abortion techniques still are problematic and are associated with a
higher mortality rate.
LEGAL ASPECTS OF INDUCED
ABORTION
 The United States Supreme Court ruled in 1973 that the restrictive abortion laws in the United States were
invalid, largely because these laws invaded the individual's right to privacy, and that an abortion could not
be denied to a woman in the first 3 months of pregnancy.
 The Court indicated that after 3 months a state may "regulate the abortion procedure in ways that are
reasonably related to maternal health" .
 After the fetus reaches the stage of viability (approximately 24 weeks) the states may refuse the right to
terminate the pregnancy except when necessary for the preservation of the life or health of the mother.
 The patient must be informed regarding the nature of the procedure and its risks, including possible
infertility or even continuation of pregnancy.
 The rights of the spouse, parents, or guardian also must be considered and permission obtained when
indicated.
CLASSIFICATION
1. Therapeutic Abortion
 There are several diverse medical and surgical disorders that are indications for
termination of pregnancy. Examples include:
 persistent cardiac decompensation, especially with fixed pulmonary hypertension;
 advanced hypertensive vascular disease or diabetes;
 and malignancy.
 In cases of rape or incest, most consider termination reasonable.
 The most common indication currently is to prevent birth of a fetus with a
significant anatomical, metabolic, or mental deformity.
CLASSIFICATION
2. Elective or Voluntary Abortion
 The interruption of pregnancy before viability at the request of the woman, but
not for medical reasons, is usually termed elective or voluntary abortion.
 Most abortions done today are elective, and thus, it is one of the most
commonly performed medical procedures.
 The pregnancy-associated mortality rate is 14-fold greater than the
abortion-related mortality rate - 8 versus 0.6 deaths per 100,000.
MEDICAL VS SURGICAL
TECHNIQUES FOR ABORTION
 In the absence of serious maternal medical disorders, abortion procedures
do not require hospitalization.
 First-trimester abortions can be performed either medically or surgically by
several methods.
 Medical therapy has more drawbacks in that it is
 more time consuming;
 it has an unpredictable outcome extending for days up to a few weeks;
 and bleeding is usually heavier and unpredictable.
CERVICAL PREPARATION
 There are several methods that will soften and slowly dilate the cervix to minimize trauma from
mechanical dilatation.
 Hygroscopic dilators and cervical ripening medications have similar efficacy in decreasing the length of
first-trimester procedures.
 Hygroscopic dilators are devices that draw water from cervical tissues and expand to gradually dilate the
cervix.
 One type is derived from various species of Laminaria algae that are harvested from the ocean floor.
 In contrast to these devices, there are medications used for cervical preparations. The most common is
misoprostol.
 The dose is 400 to 600 μg administered orally, sublingually, or placed into the posterior vaginal fornix.
 Marginal benefits ascribed to misoprostol included easier cervical dilatation and a lower composite
complication rate.
 Another effective cervical-ripening agent is the progesterone antagonist mifepristone.
 Other options include formulations of prostaglandins E2 and F2a, which have unpleasant side effects and
are usually reserved as second-line drugs
HYGROSCOPIC DEVICE
DILATION and CURETTAGE(D&C)
 Transcervical approaches to surgical abortion require first dilating the cervix
and then evacuating the pregnancy by mechanically scraping out the contents
- sharp curettage, by suctioning out the contents - suction curettage, or both.
 Curettage, either sharp or suction is recommended for gestations ≤ 15
weeks.
 Complication rates increase after the first trimester.
 Perforation, cervical laceration, hemorrhage, incomplete removal of the fetus
or placenta, and postoperative infections are among these.
DILATION and CURETTAGE (D&C)
DILATION and EVACUATION (D&E)
 Beginning at 16 weeks, fetal size and structure dictate use of this
technique.
 Wide mechanical cervical dilatation, achieved with metal or hygroscopic
dilators, precedes mechanical destruction and evacuation of fetal parts.
 With complete removal of the fetus, a large-bore vacuum curette is used
to remove the placenta and remaining tissue.
 This is better accomplished using intraoperative sonographic imaging.
Dilation and Evacuation (D&E)
DILATION and EXTRACTION (D&X)
 This is similar to dilation and
evacuation except that a suction
cannula is used to evacuate the
intracranial contents after delivery of
the fetal body through the dilated
cervix.
 This aids extraction and minimizes
uterine or cervical injury from
instruments or fetal bones.
MENSTRUAL ASPIRATION
 This is done within 1 to 3 weeks after a missed menstrual period and with a
positive serum or urine pregnancy test result.
 It is performed with a flexible 5 or 6mm Karman cannula that is attached to a
syringe.
 A distinct drawback is that because the pregnancy is so small, an implanted
zygote can be missed by the curette, or an ectopic pregnancy can be
unrecognized.
 This procedure has been referred to as menstrual extraction, menstrual
induction, instant period, traumatic abortion, and mini-abortion.
MANUAL VACUUM EVACUATION
 This procedure is similar to menstrual aspiration but is used for early
pregnancy failures or elective termination up to 12 weeks.
 For pregnancies ≤ 8 weeks, preprocedure cervical ripening is usually not
necessary.
 After this time, some recommend that osmotic dilators be placed the day prior
or misoprostol given 2 to 4 hours before the procedure.
 Paracervical blockade with or without sedation is used.
 The technique employs a hand-operated 60-Ml syringe and cannula.
 A vacuum is created in the syringe attached to the cannula, which is inserted
transcervically into the uterus.
 The vacuum produces up to 60 mm Hg suction.
 Complications are similar to other surgical methods
MEDICAL ABORTION
 Outpatient medical abortion is an acceptable alternative to surgical pregnancy
termination in appropriately selected pregnant women less than 49 days
menstrual age.
 Currently, there are only three medications for early medical abortion that have
been widely studied :
1. the antiprogestin mifepristone
2. the antimetabolite methotrexate
3. the prostaglandin misoprostol
 Mifepristone and methotrexate increase uterine contractility by reversing
progesterone induced inhibition, whereas misoprostol directly stimulates the
myometrium.
MEDICAL ABORTION
CONTRAINDICATIONS &
COMPLICATIONS
Contraindications
 In many cases, contraindications to
medical abortion evolved from exclusion
criteria that were used in initial clinical
trials.
 Thus, some are relative
contraindications:
 In situ intrauterinedevice
 Severe anemia
 Coagulopathy, or anticoagulant use
 Significant medical conditions such as
active liver disease, cardiovasculardisease
 Uncontrolled seizure disorders
Complications
 Bleeding and cramping with medical
termination can be significantly worse
than menstrual cramps.
 If there is enough blood to soak two
or more pads per hour for at least 2
hours, the woman is instructed to
contact her provider to determine
whether she needs to be seen.
CONSEQUENCES OF ELECTIVE
ABORTION
Maternal Mortality
• Mortality rate of less than 1
per 100,000 procedures
• Early abortions are even safer,
and the relative mortality risk
ofabortion approximately
doubles for each 2 weeks after
8 weeks’gestation.
Health and Future
Pregnancies
• Rates of infertility or ectopic
pregnancy are not increased.
• There may be exceptions if
there are postabortal
infections, especially those
caused by chlamydiae.
• Multiple sharp curettage
procedures may increase the
subsequent risk of placenta
previa
CONTRACEPTION
AFTER ABORTION
• Ovulation resumes as early as
2 weeks following early
pregnancy termination.
• An IUD can be inserted after
the procedure is completed
THANK YOU!!!

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Screening of high risk pregnancy
Screening of high risk pregnancyScreening of high risk pregnancy
Screening of high risk pregnancy
 
Preterm labour
Preterm labourPreterm labour
Preterm labour
 
Abortion
AbortionAbortion
Abortion
 
Hydatidiform Mole
Hydatidiform MoleHydatidiform Mole
Hydatidiform Mole
 
Ectopic Pregnancy
Ectopic PregnancyEctopic Pregnancy
Ectopic Pregnancy
 
Ectopic pregnancy
Ectopic pregnancy Ectopic pregnancy
Ectopic pregnancy
 
Breech presentation
Breech presentationBreech presentation
Breech presentation
 
Cord prolapse
Cord prolapseCord prolapse
Cord prolapse
 
Bleeding in early pregnancy
Bleeding in early pregnancyBleeding in early pregnancy
Bleeding in early pregnancy
 
Antepartum hemorrhage
Antepartum hemorrhageAntepartum hemorrhage
Antepartum hemorrhage
 
Multiple pregnancy
Multiple pregnancyMultiple pregnancy
Multiple pregnancy
 
Abnormalities of-placenta-and-cordppt
Abnormalities of-placenta-and-cordpptAbnormalities of-placenta-and-cordppt
Abnormalities of-placenta-and-cordppt
 
UTERINE DISPLACEMENT
UTERINE DISPLACEMENTUTERINE DISPLACEMENT
UTERINE DISPLACEMENT
 
Fetal distress
Fetal distressFetal distress
Fetal distress
 
Subinvolution of the uterus
Subinvolution of the uterusSubinvolution of the uterus
Subinvolution of the uterus
 
Aph
AphAph
Aph
 
Premature labour
Premature labourPremature labour
Premature labour
 
Abortion -Type and it's Management
Abortion -Type and it's ManagementAbortion -Type and it's Management
Abortion -Type and it's Management
 
NURSING MANAGEMENT OF SECOND STAGE OF LABOUR
NURSING MANAGEMENT OF SECOND STAGE OF LABOURNURSING MANAGEMENT OF SECOND STAGE OF LABOUR
NURSING MANAGEMENT OF SECOND STAGE OF LABOUR
 
Abruptio placentae
Abruptio placentae Abruptio placentae
Abruptio placentae
 

Ähnlich wie Abortion

OBSTETRICS AND GYNAECOLOGICAL NURSING- HIGH RISK PREGNANCY ABORTION.pptx
OBSTETRICS AND GYNAECOLOGICAL NURSING- HIGH RISK PREGNANCY ABORTION.pptxOBSTETRICS AND GYNAECOLOGICAL NURSING- HIGH RISK PREGNANCY ABORTION.pptx
OBSTETRICS AND GYNAECOLOGICAL NURSING- HIGH RISK PREGNANCY ABORTION.pptxmagie12
 
OBG - 14.5.20 AN UNIT - 7 ABORTION.pptx
OBG - 14.5.20 AN UNIT - 7  ABORTION.pptxOBG - 14.5.20 AN UNIT - 7  ABORTION.pptx
OBG - 14.5.20 AN UNIT - 7 ABORTION.pptxBasitRamzan1
 
Obstetric hemorrhages of the 1st half of pregnancy.ppt
Obstetric hemorrhages of the 1st half of pregnancy.pptObstetric hemorrhages of the 1st half of pregnancy.ppt
Obstetric hemorrhages of the 1st half of pregnancy.pptTARUNKUMAR472866
 
ABORTION PPT (1).pptx
ABORTION PPT (1).pptxABORTION PPT (1).pptx
ABORTION PPT (1).pptxtubegaming
 
15a.Abnormal Early Pregnancies
15a.Abnormal Early Pregnancies15a.Abnormal Early Pregnancies
15a.Abnormal Early PregnanciesDeep Deep
 
Abnormal Early Pregnancies
Abnormal  Early  PregnanciesAbnormal  Early  Pregnancies
Abnormal Early PregnanciesDeep Deep
 
ABORTION-PRESENTATION.ppt
ABORTION-PRESENTATION.pptABORTION-PRESENTATION.ppt
ABORTION-PRESENTATION.pptSimonKatanga
 
Abortion and Its Complications
Abortion and Its ComplicationsAbortion and Its Complications
Abortion and Its ComplicationsJoseph Paul, MD
 
Uterine abnormalities
Uterine abnormalitiesUterine abnormalities
Uterine abnormalitiesArifaKhan35
 

Ähnlich wie Abortion (20)

OBSTETRICS AND GYNAECOLOGICAL NURSING- HIGH RISK PREGNANCY ABORTION.pptx
OBSTETRICS AND GYNAECOLOGICAL NURSING- HIGH RISK PREGNANCY ABORTION.pptxOBSTETRICS AND GYNAECOLOGICAL NURSING- HIGH RISK PREGNANCY ABORTION.pptx
OBSTETRICS AND GYNAECOLOGICAL NURSING- HIGH RISK PREGNANCY ABORTION.pptx
 
OBG - 14.5.20 AN UNIT - 7 ABORTION.pptx
OBG - 14.5.20 AN UNIT - 7  ABORTION.pptxOBG - 14.5.20 AN UNIT - 7  ABORTION.pptx
OBG - 14.5.20 AN UNIT - 7 ABORTION.pptx
 
Obstetric hemorrhages of the 1st half of pregnancy.ppt
Obstetric hemorrhages of the 1st half of pregnancy.pptObstetric hemorrhages of the 1st half of pregnancy.ppt
Obstetric hemorrhages of the 1st half of pregnancy.ppt
 
Abortion.ppt
Abortion.pptAbortion.ppt
Abortion.ppt
 
Obstructed labor
Obstructed laborObstructed labor
Obstructed labor
 
ABORTION PPT (1).pptx
ABORTION PPT (1).pptxABORTION PPT (1).pptx
ABORTION PPT (1).pptx
 
Abortion
AbortionAbortion
Abortion
 
15a.Abnormal Early Pregnancies
15a.Abnormal Early Pregnancies15a.Abnormal Early Pregnancies
15a.Abnormal Early Pregnancies
 
Abnormal Early Pregnancies
Abnormal  Early  PregnanciesAbnormal  Early  Pregnancies
Abnormal Early Pregnancies
 
ABORTION-PRESENTATION.ppt
ABORTION-PRESENTATION.pptABORTION-PRESENTATION.ppt
ABORTION-PRESENTATION.ppt
 
Abortion and Its Complications
Abortion and Its ComplicationsAbortion and Its Complications
Abortion and Its Complications
 
Abortion
AbortionAbortion
Abortion
 
Types of Abortion
Types of AbortionTypes of Abortion
Types of Abortion
 
ABORTION.pptx
ABORTION.pptxABORTION.pptx
ABORTION.pptx
 
Miscarriage1
Miscarriage1Miscarriage1
Miscarriage1
 
NCM 109 WEEK 3
NCM 109 WEEK 3NCM 109 WEEK 3
NCM 109 WEEK 3
 
Abortion.pptx
Abortion.pptxAbortion.pptx
Abortion.pptx
 
Abortions-1.ppt
Abortions-1.pptAbortions-1.ppt
Abortions-1.ppt
 
Uterine abnormalities
Uterine abnormalitiesUterine abnormalities
Uterine abnormalities
 
uterine abnormality
uterine abnormalityuterine abnormality
uterine abnormality
 

Mehr von rod prasad

Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic feverrod prasad
 
Superior vena cava syndrome
Superior vena cava syndromeSuperior vena cava syndrome
Superior vena cava syndromerod prasad
 
Heart failure in elderly
Heart failure in elderlyHeart failure in elderly
Heart failure in elderlyrod prasad
 
Nephrolithiasis and Pyelonephritis
Nephrolithiasis and PyelonephritisNephrolithiasis and Pyelonephritis
Nephrolithiasis and Pyelonephritisrod prasad
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathyrod prasad
 
Rabies rod prasad
Rabies   rod prasadRabies   rod prasad
Rabies rod prasadrod prasad
 
Rsv rod prasad
Rsv   rod prasadRsv   rod prasad
Rsv rod prasadrod prasad
 
Pediatric multiple sclerosis
Pediatric multiple sclerosisPediatric multiple sclerosis
Pediatric multiple sclerosisrod prasad
 
Systemic lupus erythematosus
Systemic lupus erythematosusSystemic lupus erythematosus
Systemic lupus erythematosusrod prasad
 
Gonarthrosis and knee replacement
Gonarthrosis and knee replacementGonarthrosis and knee replacement
Gonarthrosis and knee replacementrod prasad
 
Sporadic colon cancer
Sporadic colon cancerSporadic colon cancer
Sporadic colon cancerrod prasad
 
Zollinger – ellison syndrome
Zollinger – ellison syndromeZollinger – ellison syndrome
Zollinger – ellison syndromerod prasad
 
Modern methods for treatment of heart failure
Modern methods for treatment of heart failureModern methods for treatment of heart failure
Modern methods for treatment of heart failurerod prasad
 
Systemic lupus erythematous
Systemic lupus erythematousSystemic lupus erythematous
Systemic lupus erythematousrod prasad
 

Mehr von rod prasad (15)

Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
Superior vena cava syndrome
Superior vena cava syndromeSuperior vena cava syndrome
Superior vena cava syndrome
 
Heart failure in elderly
Heart failure in elderlyHeart failure in elderly
Heart failure in elderly
 
Nephrolithiasis and Pyelonephritis
Nephrolithiasis and PyelonephritisNephrolithiasis and Pyelonephritis
Nephrolithiasis and Pyelonephritis
 
Jaundice
JaundiceJaundice
Jaundice
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
Rabies rod prasad
Rabies   rod prasadRabies   rod prasad
Rabies rod prasad
 
Rsv rod prasad
Rsv   rod prasadRsv   rod prasad
Rsv rod prasad
 
Pediatric multiple sclerosis
Pediatric multiple sclerosisPediatric multiple sclerosis
Pediatric multiple sclerosis
 
Systemic lupus erythematosus
Systemic lupus erythematosusSystemic lupus erythematosus
Systemic lupus erythematosus
 
Gonarthrosis and knee replacement
Gonarthrosis and knee replacementGonarthrosis and knee replacement
Gonarthrosis and knee replacement
 
Sporadic colon cancer
Sporadic colon cancerSporadic colon cancer
Sporadic colon cancer
 
Zollinger – ellison syndrome
Zollinger – ellison syndromeZollinger – ellison syndrome
Zollinger – ellison syndrome
 
Modern methods for treatment of heart failure
Modern methods for treatment of heart failureModern methods for treatment of heart failure
Modern methods for treatment of heart failure
 
Systemic lupus erythematous
Systemic lupus erythematousSystemic lupus erythematous
Systemic lupus erythematous
 

Kürzlich hochgeladen

CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 

Kürzlich hochgeladen (20)

CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 

Abortion

  • 2. INTRODUCTION  Abortion is defined as the spontaneous or induced termination of pregnancy before fetal viability.  Abortion is the process of partial or complete separation of the product of conception from the uterine wall with or without partial or complete expulsion from the uterine cavity before the age of viability.  World Health Organization define abortion as pregnancy termination before 20 weeks’ gestation or with a fetus born weighing < 500 g.
  • 4. SPONTANEOUS ABORTION  Spontaneous abortion is the most common complication of pregnancy and is defined as the passing of a pregnancy prior to completion of the 20th gestational week.  It implies delivery of all or any part of the products of conception, with or without a fetus weighing less than 500g.  80% of spontaneous abortions occur prior to 12 weeks' gestation.  The incidence of abortion is influenced by the age of the mother and by a number of pregnancy-related factors, including:  a history of a previous full-term normal pregnancy,  the number of previous spontaneous abortions,  a previous stillbirth,  and a previous infant born with malformations or known genetic defects.
  • 5. ETIOLOGY  An abnormal karyotype is present in approximately 50% of spontaneous abortions occurring during the first trimester.  The incidence decreases to 20–30% in second-trimester losses and to 5–10% in third trimester losses.  Approximately half of miscarriages are anembryonic, that is, with no identifiable embryonic elements.  Blighted ovum - represents a failed development of the embryo so that only a gestational sac, with or without a yolk sac, is present.  The other 50 percent are embryonic miscarriages, which commonly display a developmental abnormality of the zygote, embryo, fetus, or at times, the placenta.
  • 6. EMBRYONIC ANEUPLOID VS EUPLOID Aneuploid Abortion - occurs at earlier gestational ages. 75 percent of aneuploid abortions occurred by 8 weeks. Euploid Abortion - Chromosomally normal fetuses abort later than those that are aneuploid. Specifically, the rate of euploid abortions peaks at approximately 13 weeks.
  • 7. MATERNAL FACTORS  INFECTIONS - Organisms such as Treponema pallidum, Chlamydia trachomatis, Neisseria gonorrhoeae, Streptococcus agalactiae, herpes simplex virus, cytomegalovirus, and Listeria monocytogenes have been implicated in spontaneous abortion.  OTHER MEDICAL CONDITIONS - Endocrine disorders such as hyperthyroidism and poorly controlled diabetes mellitus; cardiovascular disorders, such as hypertensive or renal disease; and connective tissue disease, such as systemic lupus erythematosus.  UTERINE DEFECTS - Congenital anomalies that distort or reduce the size of the uterine cavity, such as unicornuate,bicornuate, or septate uterus, carry a 25–50% risk of miscarriage. Previous scarring of the uterine cavity following dilatation and curettage (D&C), myomectomy, or unification procedures has been implicated in spontaneous miscarriage.
  • 8. MATERNAL FACTORS  IMMUNOLOGICAL DISORDERS - Blood group incompatibility due to ABO, Rh, Kell, or other less common antigens has been associated with spontaneous abortions.  MALNUTRITION - severe dietary deficiency and morbid obesity are associated with increased miscarriage risks.  SOCIAL & BEHAVIORAL FACTORS - increased miscarriage risk are most commonly related to chronic and especially heavy use of legal substances. Eg, alcohol, cigarette smoking and caffeine.  TOXIC FACTORS - Agents such as radiation, antineoplastic drugs, anesthetic gases, lead, ethylene oxide, and formaldehyde may be embryotoxic.  TRAUMA - Direct trauma, such as injury to the uterus from a gunshot wound, or indirect trauma, such as surgical removal of an ovary containing the corpus luteum of pregnancy, may result in spontaneous abortion
  • 9. PATHOLOGY OF PREGNANCY  In spontaneous abortion, hemorrhage into the decidua basalis often occurs.  Necrosis and inflammation appear in the area of implantation. The pregnancy becomes partially or entirely detached.  Uterine contractions and dilatation of the cervix result in expulsion of most or all of the products of conception.
  • 10. THREATENED ABORTION  DEFINITION  Bleeding of intrauterine origin occurring before the 20th completed week, with or without uterine contractions, without dilatation of the cervix, and without expulsion of the products of conception.  CLINICAL FEATURE  Bleeding (minimal, painless)  Clearly rhythmic cramps  Persistent low backache with pelvic pressure  Dull and midline suprapubic discomfort.  EXAMINATION  Size of uterus is correspond to period of amenorrhea (POA)  Closed cervical os  U/S : well-formed, rounded gestational sac with fetus within it  MANAGEMENT  Bed rest  Folic acid supplements  Avoid coitus
  • 11. INEVITABLE ABORTION  DEFINITION  Bleeding of intrauterine origin before the 20th completed week, with dilatation of the cervix without expulsion of the products of conception.  It can progress to complete/ incomplete abortion depending on whether or not all fetal & placental tissues have been expelled from uterus.  CLINICAL FEATURE  Vaginal bleeding (painful)  Associated with cramping pain at lower abdomen  Abortion isinevitable when cervical effacement, cervical dilatation, and/or rupture of the membranes  EXAMINATION  Size of uterus is correspond to/less than POA  Dilated cervical os  MANAGEMENT  Hospitalization  Analgesics for control of pain
  • 12. INCOMPLETE ABORTION  DEFINITION  Expulsion of some, but not all, of the products of conception  CLINICAL FEATURE  Vaginal bleeding (heavy, passed out POC as fleshy masses)  Associated with colicky pain at lower abdomen  +/- signs of shock  EXAMINATION  Size of uterus is smaller than POA  Open cervical os  U/S : reveal retained POC in uterine cavity  MANAGEMENT  Resuscitate if bleeding is severe, do blood group and cross match  Give analgesia for pain  Evacuation retained product of conception
  • 13. COMPLETE ABORTION  DEFINITION  Expulsion of all of the products of conception before the 20th completed week of gestation  CLINICAL FEATURE  History of pain and passage of product of conception  Followed by absent of pain, minimal bleeding  EXAMINATION  Size of uterus is smaller than POA  Closed cervical os  U/S : empty uterine cavity  MANAGEMENT  Do U/S to look for empty of uterine cavity
  • 14. MISSED ABORTION  DEFINITION  The embryo or fetus dies, but the products of conception are retained in utero.  CLINICAL FEATURE  Decreased in pregnancy symptoms  Vaginal bleeding (absent, minimal)  EXAMINATION  Size of uterus is smaller than POA •  Closed cervical os •  U/S : crumpled gestational sac and/or revealed fetal pole but no signs of activity (no heart activity)  MANAGEMENT  Wait for spontaneous expulsion  Evacuation of retained product of conception
  • 15. SEPTIC ABORTION  DEFINITION  Infection of the uterus and sometimes surrounding structures occur.  CLINICAL FEATURE  Fever  Malodorous vaginal discharge  Pelvic and abdominal pain  EXAMINATION  CBC, urinalysis, endometrial cultures, blood cultures, chest x-ray, and abdominal x-ray to rule out uterine perforation.  U/S: rule out retained products of conception  MANAGEMENT  Hospitalization and intravenous antibiotic therapy  D&C and hysterectomy if the infection does not respond to treatment.
  • 17. RECURRENT ABORTION  Recurrent abortion in its broadest definition is defined as 2 to 3 or more consecutive pregnancy losses before 20 weeks of gestation, each with a fetus weighing less than 500g.  Most of these are embryonic or early losses, and the remainder either are anembryonic or occur after 14 weeks.  Prognosis for a successful subsequent pregnancy is correlated with the number of previous abortions.  The risk of having a spontaneous abortion for the first time is about 15%, and this risk is at least doubled in women experiencing recurrent abortion.
  • 18. ETIOLOGY  There are many putative causes of recurrent abortion, however,only three are widely accepted: 1. Parental Chromosomal Abnormalities  Account for only 2 to 4 percent of recurrent losses  Karyotypic evaluation of both parents is considered by many to be a critical part of evaluation.  Balanced reciprocal translocations – 50%  Robertsonian translocations – 25%  X chromosome mosaicism - 47,XXY or Klinefelter syndrome - 12 %  These chromosomal abnormalities are repetitive for consecutive losses
  • 19. ETIOLOGY 2. Anatomical Factors  Several genital tract abnormalities have been implicated in recurrent miscarriage and other adverse pregnancy outcomes, but not infertility.  Asherman syndrome usually result from destruction of large areas of endometrium following uterine curettage or ablative procedures.  Cervical incompetence, submucous leiomyomas, abnormalities due to Diethylstilbestrol (DES) exposure in utero.  Septate uteri account for the vast majority of patients with uterine malformations and recurrent pregnancy loss.  Submucous leiomyomas are responsible for a much smaller percentage of repeated losses
  • 21. ETIOLOGY 3. Antiphospholipid Syndrome  Antiphospholipid antibodies, a family of autoantibodies that bind to phospholipid-binding plasma proteins.  Women with recurrent spontaneous pregnancy loss have a higher frequency of these antibodies compared with normal pregnancies.  Antiphospholipid antibodies may damage platelets and vascular endothelium, resulting in thrombosis.  Other suspected but not proven causes are alloimmunity, endocrinopathies, environmental toxins, and various infections.
  • 23. INDUCED ABORTION  The term induced abortion is defined as the medical or surgical termination of pregnancy before the time of fetal viability.  Definitions to describe its frequency include: (1) abortion ratio - the number of abortions per 1000 live births, and (2) abortion rate - the number of abortions per 1000 women aged 15 to 44 years.  An estimated 1 of every 4 pregnancies in the world is terminated by induced abortion, making it perhaps the most common method of reproduction limitation.  Midtrimester abortion techniques still are problematic and are associated with a higher mortality rate.
  • 24. LEGAL ASPECTS OF INDUCED ABORTION  The United States Supreme Court ruled in 1973 that the restrictive abortion laws in the United States were invalid, largely because these laws invaded the individual's right to privacy, and that an abortion could not be denied to a woman in the first 3 months of pregnancy.  The Court indicated that after 3 months a state may "regulate the abortion procedure in ways that are reasonably related to maternal health" .  After the fetus reaches the stage of viability (approximately 24 weeks) the states may refuse the right to terminate the pregnancy except when necessary for the preservation of the life or health of the mother.  The patient must be informed regarding the nature of the procedure and its risks, including possible infertility or even continuation of pregnancy.  The rights of the spouse, parents, or guardian also must be considered and permission obtained when indicated.
  • 25. CLASSIFICATION 1. Therapeutic Abortion  There are several diverse medical and surgical disorders that are indications for termination of pregnancy. Examples include:  persistent cardiac decompensation, especially with fixed pulmonary hypertension;  advanced hypertensive vascular disease or diabetes;  and malignancy.  In cases of rape or incest, most consider termination reasonable.  The most common indication currently is to prevent birth of a fetus with a significant anatomical, metabolic, or mental deformity.
  • 26. CLASSIFICATION 2. Elective or Voluntary Abortion  The interruption of pregnancy before viability at the request of the woman, but not for medical reasons, is usually termed elective or voluntary abortion.  Most abortions done today are elective, and thus, it is one of the most commonly performed medical procedures.  The pregnancy-associated mortality rate is 14-fold greater than the abortion-related mortality rate - 8 versus 0.6 deaths per 100,000.
  • 28. TECHNIQUES FOR ABORTION  In the absence of serious maternal medical disorders, abortion procedures do not require hospitalization.  First-trimester abortions can be performed either medically or surgically by several methods.  Medical therapy has more drawbacks in that it is  more time consuming;  it has an unpredictable outcome extending for days up to a few weeks;  and bleeding is usually heavier and unpredictable.
  • 29. CERVICAL PREPARATION  There are several methods that will soften and slowly dilate the cervix to minimize trauma from mechanical dilatation.  Hygroscopic dilators and cervical ripening medications have similar efficacy in decreasing the length of first-trimester procedures.  Hygroscopic dilators are devices that draw water from cervical tissues and expand to gradually dilate the cervix.  One type is derived from various species of Laminaria algae that are harvested from the ocean floor.  In contrast to these devices, there are medications used for cervical preparations. The most common is misoprostol.  The dose is 400 to 600 μg administered orally, sublingually, or placed into the posterior vaginal fornix.  Marginal benefits ascribed to misoprostol included easier cervical dilatation and a lower composite complication rate.  Another effective cervical-ripening agent is the progesterone antagonist mifepristone.  Other options include formulations of prostaglandins E2 and F2a, which have unpleasant side effects and are usually reserved as second-line drugs
  • 31. DILATION and CURETTAGE(D&C)  Transcervical approaches to surgical abortion require first dilating the cervix and then evacuating the pregnancy by mechanically scraping out the contents - sharp curettage, by suctioning out the contents - suction curettage, or both.  Curettage, either sharp or suction is recommended for gestations ≤ 15 weeks.  Complication rates increase after the first trimester.  Perforation, cervical laceration, hemorrhage, incomplete removal of the fetus or placenta, and postoperative infections are among these.
  • 33. DILATION and EVACUATION (D&E)  Beginning at 16 weeks, fetal size and structure dictate use of this technique.  Wide mechanical cervical dilatation, achieved with metal or hygroscopic dilators, precedes mechanical destruction and evacuation of fetal parts.  With complete removal of the fetus, a large-bore vacuum curette is used to remove the placenta and remaining tissue.  This is better accomplished using intraoperative sonographic imaging.
  • 35. DILATION and EXTRACTION (D&X)  This is similar to dilation and evacuation except that a suction cannula is used to evacuate the intracranial contents after delivery of the fetal body through the dilated cervix.  This aids extraction and minimizes uterine or cervical injury from instruments or fetal bones.
  • 36. MENSTRUAL ASPIRATION  This is done within 1 to 3 weeks after a missed menstrual period and with a positive serum or urine pregnancy test result.  It is performed with a flexible 5 or 6mm Karman cannula that is attached to a syringe.  A distinct drawback is that because the pregnancy is so small, an implanted zygote can be missed by the curette, or an ectopic pregnancy can be unrecognized.  This procedure has been referred to as menstrual extraction, menstrual induction, instant period, traumatic abortion, and mini-abortion.
  • 37. MANUAL VACUUM EVACUATION  This procedure is similar to menstrual aspiration but is used for early pregnancy failures or elective termination up to 12 weeks.  For pregnancies ≤ 8 weeks, preprocedure cervical ripening is usually not necessary.  After this time, some recommend that osmotic dilators be placed the day prior or misoprostol given 2 to 4 hours before the procedure.  Paracervical blockade with or without sedation is used.  The technique employs a hand-operated 60-Ml syringe and cannula.  A vacuum is created in the syringe attached to the cannula, which is inserted transcervically into the uterus.  The vacuum produces up to 60 mm Hg suction.  Complications are similar to other surgical methods
  • 38. MEDICAL ABORTION  Outpatient medical abortion is an acceptable alternative to surgical pregnancy termination in appropriately selected pregnant women less than 49 days menstrual age.  Currently, there are only three medications for early medical abortion that have been widely studied : 1. the antiprogestin mifepristone 2. the antimetabolite methotrexate 3. the prostaglandin misoprostol  Mifepristone and methotrexate increase uterine contractility by reversing progesterone induced inhibition, whereas misoprostol directly stimulates the myometrium.
  • 40. CONTRAINDICATIONS & COMPLICATIONS Contraindications  In many cases, contraindications to medical abortion evolved from exclusion criteria that were used in initial clinical trials.  Thus, some are relative contraindications:  In situ intrauterinedevice  Severe anemia  Coagulopathy, or anticoagulant use  Significant medical conditions such as active liver disease, cardiovasculardisease  Uncontrolled seizure disorders Complications  Bleeding and cramping with medical termination can be significantly worse than menstrual cramps.  If there is enough blood to soak two or more pads per hour for at least 2 hours, the woman is instructed to contact her provider to determine whether she needs to be seen.
  • 41. CONSEQUENCES OF ELECTIVE ABORTION Maternal Mortality • Mortality rate of less than 1 per 100,000 procedures • Early abortions are even safer, and the relative mortality risk ofabortion approximately doubles for each 2 weeks after 8 weeks’gestation. Health and Future Pregnancies • Rates of infertility or ectopic pregnancy are not increased. • There may be exceptions if there are postabortal infections, especially those caused by chlamydiae. • Multiple sharp curettage procedures may increase the subsequent risk of placenta previa CONTRACEPTION AFTER ABORTION • Ovulation resumes as early as 2 weeks following early pregnancy termination. • An IUD can be inserted after the procedure is completed